4//SEC Filing
HARDMAN NORMAN PHD 4
Accession 0001181431-12-004258
CIK 0001333763other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 5:44 PM ET
Size
11.0 KB
Accession
0001181431-12-004258
Insider Transaction Report
Form 4
HARDMAN NORMAN PHD
Director
Transactions
- Award
Stock Option (Right to Buy)
2012-01-25+30,000→ 30,000 totalExercise: $4.54Exp: 2022-01-25→ Common Stock (30,000 underlying)
Holdings
- 30,000
Stock Option (Right to Buy)
Exercise: $7.72Exp: 2021-01-11→ Common Stock (30,000 underlying) - 35,000
Stock Option (Right to Buy)
Exercise: $4.80Exp: 2018-04-10→ Common Stock (35,000 underlying) - 30,000
Stock Option (Right to Buy)
Exercise: $1.78Exp: 2019-01-22→ Common Stock (30,000 underlying) - 30,000
Stock Option (Right to Buy)
Exercise: $2.96Exp: 2020-01-19→ Common Stock (30,000 underlying) - 5,000
Common Stock
Footnotes (5)
- [F1]Option vests in four equal annual installments beginning on January 25, 2013.
- [F2]Option vests in four equal annual installments beginning on January 11, 2012.
- [F3]Option vests in four equal annual installments beginning on January 19, 2011.
- [F4]Option vests in four equal annual installments beginning on January 22, 2010.
- [F5]Option vests in four equal annual installments beginning on April 10, 2009.
Documents
Issuer
Chelsea Therapeutics International, Ltd.
CIK 0001333763
Entity typeother
Related Parties
1- filerCIK 0001123617
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 5:44 PM ET
- Size
- 11.0 KB